Genexine (XKRX:095700) Land And Improvements : ₩23,151 Mil (As of Mar. 2024)

View and export this data going back to 2009. Start your Free Trial

What is Genexine Land And Improvements?

Genexine's land and improvements for the quarter that ended in Mar. 2024 was ₩23,151 Mil.

Genexine's quarterly land and improvements stayed the same from Sep. 2023 (₩23,151 Mil) to Dec. 2023 (₩23,151 Mil) and stayed the same from Dec. 2023 (₩23,151 Mil) to Mar. 2024 (₩23,151 Mil).

Genexine's annual land and improvements increased from Dec. 2021 (₩21,697 Mil) to Dec. 2022 (₩22,104 Mil) and increased from Dec. 2022 (₩22,104 Mil) to Dec. 2023 (₩23,151 Mil).

Genexine Land And Improvements Historical Data

The historical data trend for Genexine's Land And Improvements can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Genexine Land And Improvements Chart

Genexine Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Land And Improvements

Get a 7-Day Free Trial

6,838.57

21,696.65

22,103.74

23,150.53

Genexine Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Land And Improvements	Get a 7-Day Free Trial															22,101.19	22,101.19	23,150.53	23,150.53	23,150.53

Genexine Land And Improvements Calculation

Land is the surface or crust of the earth, which can be used to support structures, and may be used to grow crops, grass, shrubs, and trees. Land is characterized as having an unlimited life (indefinite). Land improvement is a long-term asset which indicates the cost of the constructed improvements to land, such as driveways, walkways, lighting, and parking lots.

Genexine (XKRX:095700) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Genexine Inc (XKRX:095700) » Definitions » Land And Improvements

Comparable Companies

Traded in Other Exchanges

N/A

Address

700 Daewangpangyo-ro, Gyeonggi-do, Korea Bio Park Building B, Bundang-gu, Seongnam-si, KOR, 13488

Website

http://www.genexine.com

Genexine Inc is a clinical-stage biotechnology company. It is focused on the development and commercialization of immunotherapeutics and next-generation long-acting biologics. Its primary technologies are Therapeutic DNA vaccine technology and Hyfc platform. The company's product pipeline includes products such as GX-H9, GX-E2, GX-G3, GX-G6, and Papitrol-188 among others.

Genexine (XKRX:095700) Headlines

No Headlines